SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 2 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,383,625 | -9.3% | 1,011,369 | +2.8% | 0.01% | 0.0% |
Q2 2023 | $25,781,481 | +25.9% | 983,353 | +23.6% | 0.01% | +14.3% |
Q1 2023 | $20,474,665 | +288438.1% | 795,463 | +191.5% | 0.01% | +250.0% |
Q4 2022 | $7,096 | -99.7% | 272,892 | +197.1% | 0.00% | +100.0% |
Q3 2022 | $2,617,000 | -30.5% | 91,842 | -40.0% | 0.00% | 0.0% |
Q2 2022 | $3,768,000 | -65.9% | 153,000 | -21.8% | 0.00% | -66.7% |
Q1 2022 | $11,040,000 | -7.4% | 195,539 | +1.7% | 0.00% | -25.0% |
Q4 2021 | $11,916,000 | -4.1% | 192,243 | -1.8% | 0.00% | 0.0% |
Q3 2021 | $12,423,000 | +99.8% | 195,836 | +159.3% | 0.00% | +100.0% |
Q2 2021 | $6,219,000 | – | 75,513 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,831,307 | $272,679,000 | 26.48% |
Boxer Capital, LLC | 2,075,905 | $117,164,000 | 6.02% |
Orbimed Advisors | 6,028,307 | $340,238,000 | 5.52% |
Perceptive Advisors | 4,527,993 | $255,560,000 | 5.12% |
SPHERA FUNDS MANAGEMENT LTD. | 460,025 | $25,964,000 | 3.67% |
Affinity Asset Advisors, LLC | 247,000 | $13,941,000 | 2.23% |
Artal Group S.A. | 850,000 | $47,974,000 | 2.01% |
Affinity Asset Advisors, LLC | 160,000 | $9,030,000 | 1.44% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,841,799 | $103,951,000 | 1.28% |
SPHERA FUNDS MANAGEMENT LTD. | 125,000 | $7,055,000 | 1.00% |